6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Actof 1934

For the Month of March 2020

Commission File Number 001-35948

Kamada Ltd.

(Translation of registrant’s name into English)

2 Holzman StreetScience Park, P.O. Box 4081Rehovot 7670402Israel (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨ No ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-____

This Form 6-K is being incorporated by reference intothe Registrant’s Form S-8 Registration Statements, File Nos. 333-192720, 333-207933, 333-215983, 333-222891 and 333-233267,and the Registrant’s Form F-3 Registration Statement, as amended, File No. 333-214816.

The following exhibit is attached:

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

2

EXHIBIT INDEX

3

EXHIBIT 99.1

KAMADA LTD.

2 Holzman Street

Weizmann Science Park

P.O. Box 4081

Rehovot 7670402, Israel

Notice of Results of the Extraordinary General Meeting of Shareholders held on March 25, 2020

Kamada Ltd. (the “Company”) today announced that all of the proposals presented for approval at its Extraordinary General Meeting of Shareholders held on March 25, 2020 in Rehovot, Israel (the “Meeting”), each as described in the Proxy Statement for the Meeting filed by the Company with the Securities and Exchange Commission as an exhibit to the Company’s Report on Form 6-K on February 13, 2020, were duly approved by the shareholders of the Company. Accordingly, at the Meeting, the shareholders of the Company approved the following: